Wednesday November 25 2009 | Biotechnology feed | All feeds
|
|
Sense Proteomic Limited
Download detailed PDF Members: Sense Proteomic Limited is a biomarker discovery company utilising its proprietary protein array technology to discover and commercialise autoantibody biomarkers for cancer and autoimmune diseases. We have developed a novel functional protein array technology which allows thousands of human proteins to be analysed in a single experiment. Our primary focus is on using our technology to discover new biomarker panels to improve the clinical diagnosis of cancer and autoimmune diseases. We are carrying out this work in house, in collaboration with the foremost academic researchers and in partnership with leading healthcare companies. So far our programs have generated interim data for prostate cancer, lupus and non-small cell lung carcinoma autoantibody biomarker panels which show high sensitivity and specificity.
This page has been viewed 532 times since April 2007, the link to the organisation's website has been followed 114 times Recent Search Terms used to find this page: patents held by Proteom limited Cambridge | Proteome Ltd | . Search for more companies in Maidenhead Search for more companies in Berkshire This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Sense Proteomic Limited | ||||||||||||||||||||||||||||||||||||||||||||||
|